FDA

Getting “Patients Included” right Part II: Planning a patient-centric event

Conditions, Patient Experiences / By

You may remember Part I of this blog that focused on the experiences of two PatientsLikeMe members who attended the Kidney Health Initiative’s (KHI) workshop, “Understanding patients’ preferences: Stimulating medical device development in kidney disease,” back in August. KHI is a partnership between the U.S. Food and Drug Administration (FDA) and the American Society of […]

Getting “Patients Included” right Part II: Planning a patient-centric event Read More »

Getting “Patients Included” right Part I: Two members attend a Kidney Health Initiative workshop

Patient Experiences / By

Back in August, the Kidney Health Initiative (KHI), a partnership between the U.S. Food and Drug Administration (FDA) and the American Society of Nephrology (ASN), held a workshop called “Understanding patients’ preferences: Stimulating medical device development in kidney disease.” But this was more than a workshop – it was an event centered around the idea

Getting “Patients Included” right Part I: Two members attend a Kidney Health Initiative workshop Read More »

A patient’s perspective: member Gary reports back from the FDA public meeting on Parkinson’s disease

Conditions, Parkinson's Disease, Patient Experiences / By

Back in September, Sally Okun, Vice President of Advocacy, Policy and Patient Safety, and community moderator Molly Cotter, attended the FDA public meeting on Parkinson’s disease (PD) along with PatientsLikeMe member Gary (tupelo). We posted some interesting developments from the meeting in the forum, but we also caught up with Gary for his perspective on

A patient’s perspective: member Gary reports back from the FDA public meeting on Parkinson’s disease Read More »

Sally Okun explains the new research collaboration with the FDA

1 Comment / Patient Experiences / By

Yesterday, we announced a new research collaboration with the U.S. Food and Drug Administration (FDA) that will explore how patient-reported data can lead to new insights about drug safety. It’s the first time the FDA will analyze patient-generated data for pharmacovigilence (aka drug safety). But we’re no strangers to drug safety. Check out some of

Sally Okun explains the new research collaboration with the FDA Read More »

PatientsLikeMe and the FDA Sign Research Collaboration Agreement

4 Comments / Patient Experiences / By

WASHINGTON D.C., June 15, 2015—PatientsLikeMe and the U.S. Food and Drug Administration (FDA) have signed a research collaboration agreement to determine how patient-reported data can give new insights into drug safety. Under the collaboration, PatientsLikeMe and the FDA will systematically explore the potential of patient-generated data to inform regulatory review activities related to risk assessment

PatientsLikeMe and the FDA Sign Research Collaboration Agreement Read More »

PatientsLikeMe members to be highlighted in patient empowerment webinar

Epilepsy, Idiopathic Pulmonary Fibrosis, Patient Experiences / By

Many PatientsLikeMe members talk openly about the reasons why they donate their health data and why they believe patient-centered healthcare means better healthcare for all. And just a week from now, two of them will be sharing their stories with everyone in a live webinar. On Tuesday, January 20th, at 2:00pm EST, the Partnership to

PatientsLikeMe members to be highlighted in patient empowerment webinar Read More »

“We are many” – PatientsLikeMe member Laura reports back on her experiences as a panelist at the FDA Patient-Focused Drug Development Public Meeting on IPF

1 Comment / Idiopathic Pulmonary Fibrosis, Patient Experiences, Pulmonary fibrosis / By

Just yesterday, you saw our very own Sally Okun RN, Vice President of Advocacy, Policy and Patient Safety, reported back about her experiences at the FDA Patient-Focused Drug Development Public Meeting on IPF. And today, we wanted to share the patient experience. For each public meeting, the FDA invites patients and caregivers to apply to

“We are many” – PatientsLikeMe member Laura reports back on her experiences as a panelist at the FDA Patient-Focused Drug Development Public Meeting on IPF Read More »

Sally Okun reports back from the FDA Patient-Focused Drug Development Public Meeting on IPF

Idiopathic Pulmonary Fibrosis, Patient Experiences, Pulmonary fibrosis / By

On September 26th I was at the FDA for the Patient-Focused Drug Development Public Meeting on IPF. This is one of 20 meetings that the FDA is holding to learn directly from patients and their caregivers about daily life with the specific condition’s symptoms and treatments. (You can learn more about these meetings here.) I have attended

Sally Okun reports back from the FDA Patient-Focused Drug Development Public Meeting on IPF Read More »

Improving drug safety through the patient voice

3 Comments / Patient Experiences / By

At PatientsLikeMe we’re interested in bringing the voice of our patients to the attention of those who make drug products and to the regulators that approve them. Since 2008 we have conducted a series of projects to collect safety information from some of our member communities. We’ve worked with our pharmaceutical partners to help them

Improving drug safety through the patient voice Read More »

Patient-focused organizations join forces to build awareness and participation

Patient Experiences / By

The innovative medical research philanthropy Cures Within Reach has announced a marketing partnership with PatientsLikeMe to work together to improve patient lives. Sep. 10, 2013 – SKOKIE, Ill — Cures Within Reach, a non-profit focused on research to repurpose existing compounds for new and immediate use, and PatientsLikeMe, a patient network and real-time research platform, are

Patient-focused organizations join forces to build awareness and participation Read More »

Scroll to Top